Cited by 108Lipid metabolism and disordersDiabetes, Cardiovascular Risks, and LipoproteinsNutrition, Genetics, and Disease

Polymorphisms in the Fatty Acid-Binding Protein 2 and Apolipoprotein C-III Genes Are Associated with the Metabolic Syndrome and Dyslipidemia in a South Indian Population

Guettier, Jean-Marc, Georgopoulos, Angeliki, Tsai, Michael Y., Radha, Venkatesan, Shanthirani, Subramaniam, Deepa, Raj, Gross, Myron, Rao, Gundu +1 more·2005·The Journal of Clinical Endocrinology & Metabolism

Abstract

The Chennai Urban Population Study investigates a South Indian population with a high prevalence of cardiovascular disease associated with the metabolic syndrome (MS). The Ala54Thr polymorphism in the fatty acid-binding protein 2 (FABP2) gene as well as the T-455C and C-482T polymorphisms in the apolipoprotein C-III (APOC3) gene promoter have been associated with features of the MS in specific populations. This study evaluates in Asian-Indians the association between these polymorphisms with MS and dyslipidemia, defined according to National Cholesterol Education Program Adult Treatment Panel III. Allelic frequencies in 70 controls and 110 patients with diabetes from the Chennai Urban Population Study were 52.9% for FABP2 Thr54, 73.0% for APOC3 -482T, and 80.2% for APOC3 -455C. The polymorphisms were in agreement with Hardy-Weinberg equilibrium. Controls carrying FABP2 Thr54 were more likely to have MS than noncarriers (Fisher's exact test P = 0.031; odds ratio = 6.9 with a 95% confidence interval of 1.1, 43.9). Those carrying at least one polymorphic allele in both genes had a higher likelihood of having MS than wild type (Fisher's exact test P = 0.003; odds ratio = 12.1 with a 95% confidence interval of 1.88, 77.6). Dyslipidemia was associated with the polymorphism as well. The polymorphisms were not associated with MS in patients with diabetes. The association of the polymorphisms with MS and dyslipidemia could contribute to the high cardiovascular disease prevalence in this population.

Integrity signals

Registry

Crossref · 10.1210/jc.2004-1338

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Previous studies have suggested that two single-nucleotide polymorphisms in the gene encoding apolipoprotein C3 (APOC3) may be associated with hypertriglyceridemia.

    “Previous studies have suggested that two single-nucleotide polymorphisms (SNPs) in the gene encoding apolipoprotein C3 (APOC3) may be associated with hypertriglyceridemia.4–8”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Guettier, J.-M., Georgopoulos, A., Tsai, M. Y., Radha, V., Shanthirani, S., Deepa, R., Gross, M., Rao, G., & Mohan, V.
Affiliations
  • University of Minnesota (US)
  • Madras Diabetes Research Foundation (IN)
Corresponding author
Georgopoulos, Angeliki
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2005-03
Volume
90
Issue
3
Pages
1705-1711
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2085689054
Cited by
108
References
49
Citations by year
2026: 1 · 2025: 3 · 2024: 5 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 3 · 2018: 5 · 2017: 7 · 2016: 5 · 2014: 11 · 2013: 3 · 2012: 1
FWCI
6.58
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Nutrition, Genetics, and Disease
Keywords
fatty acid binding protein 2, apolipoprotein C-III, metabolic syndrome, dyslipidemia, Asian Indians, South Indian population, diabetes mellitus, cardiovascular disease, genetic susceptibility
MeSH terms
Adult, Aged, Apolipoproteins C, Carrier Proteins, Female, Gene Frequency, Humans, Hyperlipidemias, India, Male, Middle Aged, Polymorphism, Genetic, Promoter Regions, Genetic, Risk Factors, Prevalence, Genetic Predisposition to Disease, Metabolic Syndrome, Asian People, Fatty Acid-Binding Proteins, Apolipoprotein C-III

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review